Literature DB >> 30287937

HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center.

Sung Kwan Bae1, Toshifumi Gushima2, Noriyuki Saito3, Ikumi Yamanaka3, Yayoi Matsuo3, Shuro Yoshida3, Ichiro Kawano3, Hideho Henzan3, Shinji Shimoda4, Tetsuya Eto3, Kazuhiro Takahashi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30287937     DOI： 10.1038/s41409-018-0355-6

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

Review 1.  HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review.

Authors:  Giuseppe Gentile; Guido Antonelli
Journal:  Viruses       Date:  2019-11-10       Impact factor: 5.048

Review 2.  Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yibo Wu; He Huang; Yi Luo
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

3.  Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma.

Authors:  Tasuku Hara; Kohei Oka; Naoto Iwai; Yutaka Inada; Toshifumi Tsuji; Takashi Okuda; Akihiro Nagata; Toshiyuki Komaki; Keizo Kagawa
Journal:  Intern Med       Date:  2020-09-19       Impact factor: 1.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.